Entecavir hydrate
CAS No. 209216-23-9
Entecavir hydrate ( Baraclude; BMS 200475; SQ 34,676 )
Catalog No. M13277 CAS No. 209216-23-9
Entecavir, a new deoxyguanine nucleoside analogue, is a selective inhibitor of the replication of the hepatitis B virus (HBV).
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 41 | In Stock |
|
10MG | 69 | In Stock |
|
25MG | 104 | In Stock |
|
50MG | 146 | In Stock |
|
100MG | 249 | In Stock |
|
200MG | 365 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEntecavir hydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionEntecavir, a new deoxyguanine nucleoside analogue, is a selective inhibitor of the replication of the hepatitis B virus (HBV).
-
DescriptionEntecavir, a new deoxyguanine nucleoside analogue, is a selective inhibitor of the replication of the hepatitis B virus (HBV).
-
SynonymsBaraclude; BMS 200475; SQ 34,676
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorHBV( HepG2 cell)
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number209216-23-9
-
Formula Weight295.30
-
Molecular FormulaC12H15N5O3·H2O
-
Purity>98%(HPLC)
-
SolubilityDMSO: 59 mg/mL (199.8 mM)
-
SMILESC=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2NC(=NC3=O)N.O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Levine S, et al. Antimicrob Agents ChemOthers, 2002, 46(8), 2525-2532.
molnova catalog
related products
-
GLS4
GLS4 (Morphothiadin) is a potent inhibitor of HBV capsid assembly, inhibits HBV replication (EC50=62.24 nM) and reduces HBV-DNA levels in HepG.2.2.15 cells (IC50=14 nM).
-
Vebicorvir
Vebicorvir is a first-generation hepatitis B virus (HBV) core protein inhibitor, has demonstrated effective antiviral activity.
-
RO6889678
RO6889678 is a highly potent inhibitor of HBV capsid formation with attributes that are favorable for targeting the liver, whilst maintaining moderate peripheral exposure.